USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SEQUELA
Address:
6508 Old Floydsburg Road
Pewee Valley, KY
Phone:
N/A
URL:
N/A
EIN:
43509005
DUNS:
189577070
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $996,069.00 2
SBIR Phase II $2,589,558.00 2

Award List:

A Uroguanylin Based ELISA for Salt Sensitivity

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$403,642.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION: This proposal is submitted in response to the program announcement PA-03-123 "Development of diagnostic screening test for salt sensitivity (SBIR/STTR)" from the National Institute of Diabetes and Digestive and Kidney Diseases. The overall hypothesis of our laboratory is the principle… More

A Test for Salt Sensitivity in People with Essential Hypertension

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$914,453.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Project Summary: In Phase I we developed a model system and a prototype Salt Sensitivity Assay to establish proof-of-principle . In Phase II we propose the evaluation of the prototype that will quantitatively measure our biomarker in the target… More

Biomarker for Early Detection of Chronic Kidney Disease

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$592,427.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This proposal is submitted in response to the program announcement PA-09-080, Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) and intende d to be directed to the NIDDK, with a… More

BIOMARKER FOR EARLY DETECTION OF CHRONIC KIDNEY DISEASE

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$1,675,105.00
Agency:
HHS
Principal Investigator:
Stephen L. Carrithers – 502-432-7712
Abstract:
DESCRIPTION (provided by applicant): There are an estimated 26 million Americans with early chronic kidney disease (CKD). Early diagnosis and treatment are the only cost-effective means to reverse this growing problem. NIH recognizes the challenge to diagnose CKD early during its initiation and… More